Company renamed VSee Health, Inc.
Shares to trade on Nasdaq under the ticker
“VSEE” on June 25, 2024
Digital Health Acquisition Corp. (Nasdaq: DHAC), a
Special Purpose Acquisition Company (SPAC), today announced the
closing of its previously announced business combination consisting
of the merger of Digital Health Acquisition Corp. with each of VSee
Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc. In connection
with the closing, Digital Health Acquisition Corp. has been renamed
VSee Health, Inc. (“VSee Health”), and effective with the start of
trading on June 25, 2024, VSee Health common stock will trade on
the Nasdaq Stock Market under the ticker symbol “VSEE” and VSee
Health warrants will trade on the Nasdaq Stock Market under the
ticker symbol “VSEEW”.
In conjunction with the transaction, VSee Health named Milton
Chen and Imoigele “Imo” P. Aisiku as co-CEOs, and Jerry Leonard as
CFO.
“The completion of this transaction marks the transition of
Digital Health Acquisition Corp. from a SPAC to an operating
company. We believe that VSee Health is poised to leverage the
combined strengths of VSee Lab and iDoc Virtual Telehealth
Solutions in the rapidly growing digital health market, aiming to
drive innovation and deliver cutting-edge solutions that enhance
patient outcomes and streamline the delivery of telemedicine,” said
Milton Chen, co-CEO of VSee Health.
“The global digital health market is experiencing rapid growth,
driven by increasing demand for remote healthcare services and the
adoption of advanced technologies. We believe that VSee Health is
positioned to potentially capture a significant share of this
market, leveraging our comprehensive suite of solutions and strong
industry relationships to help unify a complex landscape of
technologies into a single interface for healthcare providers of
all sizes,” added Imo Aisiku, co-CEO of VSee Health.
Milton Chen, PhD, co-founder of VSee Lab, has more than 20 years
of experience in the telemedicine industry and has made significant
contributions to the development and implementation of advanced
telehealth solutions. He earned a BS in Computer Science from the
University of California Berkeley and his PhD in Electrical
Engineering from Stanford University, where he focused on video and
telecommunication technologies.
Imo Aisiku, MD, founder and CEO of iDoc, is a seasoned
healthcare executive with experience in emergency medicine and
healthcare technology. Dr. Aisiku is board certified in emergency
medicine, critical care and neurocritical care. He received his MD
from the University of Massachusetts, and completed his emergency
medicine and critical care training at Emory University and his
neurocritical care training at Washington University. Dr. Aisiku
holds an MBA from Emory University and is an Associate Professor at
Harvard Medical School.
About VSee Health
VSee Health, Inc. (Nasdaq: VSEE) combines the businesses of VSee
Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc.
VSee Lab, Inc. is a no-code or low-code software as a service
(SaaS) platform that enables clinicians and enterprises to create
their telehealth workflows without programming. VSee’s system
allows a telehealth mobile app to be created or a telehealth system
to be integrated into existing hospital operations in days.
iDoc Virtual Telehealth Solutions, Inc. is an acute care
organization, set of integrated telehealth technologies and team of
neurointensivists, neurologists, tele-radiologists that treat and
coordinate care for acutely ill patients 24/7 in the neurointensive
care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU)
and the intensive care unit (ICU) for stroke, brain trauma and a
wide range of neurological conditions.
More information can be found at
www.digitalhealthacquisition.com, www.vseehealth.com, www.VSee.com
and www.iDocvms.com.
Forward-Looking Statements
This press release contains, and certain oral statements made by
representatives of Digital Health, VSee and iDoc and their
respective affiliates, from time to time may contain,
“forward-looking statements” within the meaning of the “safe
harbor” provisions of the Private Securities Litigation Reform Act
of 1995. Digital Health’s, VSee’s and iDoc’s actual results may
differ from their expectations, estimates and projections and
consequently, you should not rely on these forward-looking
statements as predictions of future events. Words such as “expect,”
“estimate,” “project,” “budget,” “forecast,” “anticipate,”
“intend,” “plan,” “may,” “will,” “could,” “should,” “believes,”
“predicts,” “potential,” “might” and “continues,” and similar
expressions are intended to identify such forward-looking
statements. These forward-looking statements include, without
limitation, Digital Health’s, VSee’s and iDoc’s expectations with
respect to future performance and anticipated financial impacts of
the Transactions contemplated by the Amended BCA. These
forward-looking statements involve significant risks and
uncertainties that could cause actual results to differ materially
from expected results. Most of these factors are outside of the
control of Digital Health or VSee and iDoc and are difficult to
predict. Factors that may cause such differences include but are
not limited to: (i) the failure to realize the anticipated benefits
of the Transactions; (ii) the ability of the Company to compete
effectively in a highly competitive market; (iii) the ability to
protect and enhance VSee and iDoc’s corporate reputation and brand;
(iv) the impact from future regulatory, judicial, and legislative
changes in VSee and iDoc’s or the Company’s industry; (v) the
uncertain effects of the COVID-19 pandemic and geopolitical
developments; (vi) competition from larger technology companies
that have greater resources, technology, relationships and/or
expertise; (vii) future financial performance of the Company
following the Transactions, including the ability of future
revenues to meet projected annual bookings; (viii) the ability of
the Company to forecast and maintain an adequate rate of revenue
growth and appropriately plan its expenses; (viii) the ability of
the Company to generate sufficient revenue from each of its revenue
streams; (ix) the ability of the Company’s patents and patent
applications to protect the Company’s core technologies from
competitors; (x) the Company’s ability to manage a complex set of
marketing relationships and realize projected revenues from
subscriptions, advertisements; product sales and/or services; (xi)
the Company’s ability to execute its business plans and strategy,
including potential expansion into new geographic regions; and
(xxiii) other risks and uncertainties described herein, as well as
those risks and uncertainties discussed from time to time in other
reports and other public filings with the SEC by Digital Health.
The foregoing list of factors is not exclusive. Should one or more
of these risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those indicated or anticipated by such forward-looking
statements. Readers are cautioned not to place undue reliance upon
any forward-looking statements, which speak only as of the date
made. Digital Health, VSee and iDoc undertake no obligation to
update forward-looking statements to reflect events or
circumstances after the date they were made except as required by
law or applicable regulation.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240624906343/en/
LHA Investor Relations Tirth T. Patel 212-201-6614
tpatel@lhai.com
Digital Health Acquisition (NASDAQ:DHAC)
Historical Stock Chart
From May 2024 to Jun 2024
Digital Health Acquisition (NASDAQ:DHAC)
Historical Stock Chart
From Jun 2023 to Jun 2024
